drugset / Trial / NCT01485965
A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study is to assess the effect of food upon the pharmacokinetics (PK) of SEN0014196 in subjects with Huntington disease (HD).
Timeline
- Start
- 2011-11
- Primary completion
- 2012-11
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SEN0014196 | Unknown | 100 mg | Oral |